Yes, all the hand-wringing, chicken little sky is falling on liehub, worrying about NP’s salary, NP’s options, NP’s first language isn’t English, working about sales without a partnership because their other OTC company can’t sell their vaccine. If mono or cancer is successful, none of that matters, this will be big time and sell itself. Same with GvHd.

For combo, leronlimab is a superior drug to what is in the market. Yes, without a partnership, they would have to put in the work networking, building a sales team, but many MDs participating in the offering. All of them are telling us, this product will sell. We just need to inform the MDs about they superior product.